Mivtach Shamir Holdings Ltd (TLV:MISH)

Intra-Cellular Therapies Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	322.57	327.02	60.51	28.95	176.25	200.55
Short-Term Investments	8.5	-	-	-	-	-
Cash & Short-Term Investments	331.06	327.02	60.51	28.95	176.25	200.55
Cash Growth	1.73%	440.47%	109.02%	-83.58%	-12.12%	10.95%
Accounts Receivable	-	-	-	-	52.35	99.23
Other Receivables	7.77	32.97	1.56	3.61	5.21	15.57
Receivables	1,637	1,521	1,133	532.04	275.77	338.12
Inventory	12.28	12.21	12.21	11.88	10.02	10.02
Other Current Assets	-	0.58	1.23	20.17	-	2.39
Total Current Assets	1,980	1,860	1,207	593.03	462.04	551.08
Property, Plant & Equipment	11.09	11.52	5.48	6.6	6.63	3.67
Long-Term Investments	1,088	1,071	1,151	1,070	837.28	798.23
Goodwill	9.73	9.73	9.73	9.82	9.82	9.82
Long-Term Accounts Receivable	-	-	-	-	104.46	84.91
Long-Term Deferred Tax Assets	4.39	4.24	2.77	1.79	4.33	3.35
Long-Term Deferred Charges	0.43	0.44	0.46	0.87	0.83	-
Other Long-Term Assets	147.76	124.17	86.13	53.88	52.57	42.96
Total Assets	5,146	4,876	4,059	3,319	2,210	1,929
Accrued Expenses	-	27.38	20.39	15.13	12.7	16.61
Current Portion of Long-Term Debt	982.4	1,206	736.55	288.66	60.53	146.01
Current Portion of Leases	0.88	0.88	0.77	0.75	0.7	0.58
Current Income Taxes Payable	24.33	38.86	18.18	7.05	12.57	8.07
Current Unearned Revenue	-	-	-	0.14	0.58	1.17
Other Current Liabilities	28.38	13.15	11.25	17.74	13.3	13.09
Total Current Liabilities	1,036	1,286	787.14	329.47	100.37	185.53
Long-Term Debt	1,985	1,511	1,580	1,503	802.53	510.56
Long-Term Leases	8.28	8.39	2.6	3.32	3.92	1.96
Long-Term Deferred Tax Liabilities	3.58	3.29	4.2	7.09	-	-
Other Long-Term Liabilities	15.3	14.92	13.46	2.57	2.83	3.1
Total Liabilities	3,049	2,824	2,388	1,846	910.03	701.57
Common Stock	49.3	49.3	49.3	49.3	49.3	49.27
Additional Paid-In Capital	261.9	259.53	260.87	259.66	261.69	256.11
Retained Earnings	1,235	1,204	1,171	1,031	890.26	830.5
Treasury Stock	-100.78	-100.78	-86.59	-86.59	-86.59	-86.59
Comprehensive Income & Other	250.67	247.24	43.11	37.16	28.96	42.32
Total Common Equity	1,696	1,660	1,438	1,290	1,144	1,092
Minority Interest	401.25	392.11	233.15	183.14	156.82	135.71
Shareholders' Equity	2,097	2,052	1,671	1,473	1,300	1,227
Total Liabilities & Equity	5,146	4,876	4,059	3,319	2,210	1,929
Total Debt	2,977	2,727	2,320	1,796	867.67	659.11
Net Cash (Debt)	-2,646	-2,400	-2,260	-1,767	-691.42	-458.55
Net Cash Per Share	-278.27	-251.98	-236.65	-185.03	-72.42	-48.17
Filing Date Shares Outstanding	9.46	9.42	9.55	9.55	9.55	9.52
Total Common Shares Outstanding	9.46	9.42	9.55	9.55	9.55	9.52
Working Capital	944.2	574.21	420.21	263.57	361.67	365.54
Book Value Per Share	179.25	176.19	150.61	135.14	119.78	114.67
Tangible Book Value	1,687	1,650	1,428	1,280	1,134	1,082
Tangible Book Value Per Share	178.22	175.16	149.59	134.11	118.75	113.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.